Winning Teams

Chosen by an independent panel of judges, the grand prize winning solutions are radically affordable compared to what is currently available on the market; and are comparable to commercial offerings at measuring sensitivity, specificity and limit of detection, with a maximum turnaround time of 12 hours from sample to result.

The winning teams are:

Reliable LFC, LLC

Reliable LFC, LLC

Antigen Testing
Carlsbad, United States

ChromaCode

ChromaCode

RNA Testing
Carlsbad, United States

Mirimus

Mirimus

RNA Testing
Brooklyn, United States

La Jolla Institute for Immunology

La Jolla Institute for Immunology

RNA Testing
La Jolla, United States

Alveo Technologies

Alveo Technologies

RNA Testing
Alameda, United States

Additionally, four other teams were selected as winners in the Open Innovation Track, whose approaches demonstrated high potential for impactful screening solutions, but could not be categorized as polymerase chain reaction (PCR), Isothermal Amplification, Next Generation Sequencing, or Antigen Detection and could not be tested through the competition rounds. 

The four winning teams in the Open Innovation Track are: 

Steradian Technologies, Inc.

Steradian Technologies, Inc.

Houston, United States

U-smell-it

U-smell-it

Guilford, United States

Ram Global

Ram Global

Zweibrücken, Germany

TeraGroup

TeraGroup

Herzliya, Israel


Meet the Finalists

Out of 219 teams, these remaining teams have demonstrated capabilities to develop Covid-19 tests for screening that are radically affordable compared to what is currently available on the market, that are comparable to commercial offerings at measuring sensitivity, specificity and limit of detection, with a maximum turnaround time of 12 hours from sample to result. Just one COVID-19 test option is not enough to meet society’s daily demands. XPRIZE Rapid Covid Testing recognizes the need for multiple testing solutions, awarding prizes to innovations in different categories — PCR, Isothermal Amplification, Next Generation Sequencing, and Antigen Detection. The diversification of testing options will help enable safe return to school and work, faster. 

Team Name     City   Country
19-Xolution     Pathum Thani   Thailand
Alveo Technologies, Inc.     Alameda   USA
Biomeme     Philadelphia   USA
Boston Biopharma & Access Bio     Roswell   USA
ChromaCode     Carlsbad   USA
Clip COVID (by Luminostics)     Milpitas   USA
CovidNudge     London   UK
GeneSurge     Munich   Germany
Genome ResearchLimited     Cambridge   UK
Highfield Diagnostics     Southampton   UK
LJI     La Jolla   USA
Mirimus     Brooklyn   USA
Molecular Mirror     San Diego   USA
Molecular Systems Lab     Boston   USA
Nanomix     Emeryville   USA
PROMPT     Baltimore   USA
Reliable-LFC, LLC     Salt Lake City   USA
Stanford Microfluidics Lab and Purigen Biosystems     Stanford   USA
UCSF COV2home     San Francisco   USA
ViralAlert     Oakland   USA


Meet the Open Innovation Teams

Additionally, 10 other teams were selected to advance in the Open Innovation Track, whose approaches demonstrated high potential for impactful screening solutions, but could not be categorized as polymerase chain reaction (PCR), Isothermal Amplification, Next Generation Sequencing, or Antigen Detection and could not be tested through the competition rounds. At the discretion of the judging panel, top teams in this track will be eligible to win a share of $500,000. These teams may choose to perform testing at a deployment site and upon successful completion are eligible to share an additional award of up to $500,000.

Team Name     City     Country
Smart Spectra     Casablanca     Morocco
u-Smell-it™     Guilford     USA
Azar Utah     Salt Lake City     USA
CRISP19     Rosario     Chile
Tapestry     New York     USA
TeraGroup     Herzliya     Israel
Worlds PROTECT     Dallas     USA
Steradian Technologies, Inc.     Houston     USA
RAM Global     Zweibrücken     Germany
Cellex, Inc.     Research Triangle Park     USA